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1. Introduction
 
   Oral route is the most preferable and convenient route 
of administration as it offers advantages like ease of 
administration, highly versatile, patient compliance and 
accurate dosing[1]. The most popular solid dosage forms 
are being tablets and capsules. One important drawback 
of these dosage forms for some patients, is the difficulty 
to swallow and readily access to water for easy swallowing 
dosage[2]. Difficulty in swallowing (dysphasia) is also 
a common problem of all age groups, especially the 
elderly and paediatrics, because of physiological changes 
associated with these groups[3]. Fast dissolving drug 
delivery is rapidly gaining acceptance as an important new 
drug delivery technology which aims to enhance safety 
and efficacy of drug molecule by formulating a convenient 
dosage form for administration and to achieve better patient 
compliance[4]. The fast dissolving tablet (FDT) has remarkable 
disintegration properties and it can rapidly disintegrate 
without water in the mouth within few seconds. When an 
FDT is placed in the oral cavity, saliva quickly penetrates 
into the pores causing rapid disintegration[5]. Based on 
the absolute bioavailability of diclofenac sodium[6], tablet 
is about 50-60%. The half-life is 2 h and highly protein 
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bound (>99%). In the bioavailability classification system, 
diclofenac is classified as a class II drug, because of its low 
water solubility and high permeability. The bioavailability 
of drug is significantly greater than those observed from 
conventional tablet dosage form. Usually, superdisintegrants 
are added to a drug formulation to facilitate the break-up 
or disintegration of tablet or capsule content into smaller 
particles that can dissolve more rapidly than drugs in the 
absence of disintegrates. Many superdisintegrants like cross 
povidone, croscarmellose sodium (Ac-di-sol) and sodium 
starch glycolate (SSG) have been used in the formulations 
of FDTs. In the present study it was proposed to formulate 
an oral drug delivery, in the form of FDTs by using direct 
compression method[7]. The purpose of the present study 
was to extract the fenugreek gum, evaluate its powder flow 
properties (bulk density, tapped density, angle of repose, 
Carr’s index and hausner ratio), swelling index and loss on 
drying and to compare disintegration efficiency of fenugreek 
gum with widely used synthetic superdisintegrants i.e. SSG 
and croscarmellose sodium in the formulation of FDTs. All 
the superdisintegrants were used  in optimized concentration 
levels to assess their efficiency. The tablets were evaluated 
in various physical tests. The formulation of a FDTs, thus 
containing diclofenac sodium and fenugreek gum, produces 
additive anti-inflammatory activity resulting in reduction 
in a dose of diclofenac sodium and thereby its dose related 
side effects.
2. Materials and methods
2.1. Materials
   Fenugreek seeds, diclofenac sodium (Harman Finochem 
Ltd, Mumbai), microcrystalline cellulose (SD Fine 
Chemicals), SSG (SD Fine Chemicals), croscarmellose 
sodium (Arrow Chem. Product., Mumbai), hexane (SD Fine 
Chemicals) and all other ingredients used throughout the 
study were of analytical grades.
2.2. Methods
2.2.1. Extraction and purification of fenugreek gum 
   Fenugreek seed (100 g) were ground to 100 mesh using a 
laboratory mill. The fine powder was extracted with boiling 
hexane in Soxhlet apparatus for 80 min. The obtained extract 
was treated with 95% ethanol (maintaining its boiling point) 
for 130 min in a conical flask to remove the unwanted 
saponin. Further enzyme deactivated was initiated by 
refluxing the extract with 70% ethanol for 180 min. The 
resulting mixture was repeatedly treated with ethanol to 
remove undissolved traces if necessary. The residue was 
filtered through sintered glass at room temperature. The 
filtered residue was subjected to mechanical stirring 
at 700 r/min with addition of water for 8 h. The obtained 
mixture was centrifuged at 5 000 r/min for 12 min at 10 °C. 
The supernatant contained crude fenugreek gum, which was 
decanted and precipitated by adding of ethanol (70%). Thus 
the gum precipitate was washed with acetone, diethyl ether 
and water. The pure fenugreek gum was oven dried[8].  
2.2.2. Physicochemical characterization of gum
   The purified and dried extracted gum powder was 
evaluated for its micromeritic properties, viscosity, solubility 
studies, swelling index and loss on drying.
2.2.2.1. Swelling index
   The study was carried out by using a 100 mL stoppered 
graduated cylinder. The initial bulk volume of 1 g of 
fenugreek gum was noted. Water was added in sufficient 
quantity to ensure 25 mL of uniform dispersion by vigorously 
shaking every 10 min for 1 h and then allowed to stand for 
24 h. The dispersion was stored at room temperature and the 
sediment volume of the swollen mass was measured after 
24 h[9].
   Swelling index=100伊(V2-V1/V1)
  Where, V1=Initial volume of material before hydration; 
V2=Volume of hydrated material.
2.2.2.2. Viscosity
   One gram of fenugreek gum powder was suspended 
in 75 mL of distilled water for 4 h. Distilled water was 
added up to 100 mL to produce the concentration of 1%. The 
mixture was homogenized by mechanical stirrer for 2 h and 
its viscosity was determined by using Brookfield viscometer, 
spindle SC4-18 (Brookfield Viscometer, DV-2+LV) at 5 r/
min[10].
2.2.2.3. Loss on drying
   Loss on drying technique is used to determine high levels 
of moisture or solvents present in the sample. The material 
sample was weighed (W1) and heated in an oven for 2 h. It 
was cooled in the dry atmosphere of desiccators and then 
finally weighed (W2). 
   % Loss on drying=[(W1-W2)/W1]伊100
   Where, W1=Initial weight of the powder; W2=Final weight 
of the powder.
2.2.3. Characterization of drug and excipients
2.2.3.1. Drug-excipient compatibility studies
   The physicochemical compatibility between diclofenac 
sodium and fenugreek gum used in the research were 
assessed by subjecting to infrared spectral studies. The 
samples were scanned under diffuse reflectance mold and 
the graph was plotted by KBr pellet method. Its spectra were 
recorded in the wavelength region between 4 000 cm-1 to 
400 cm-1. The spectra of diclofenac sodium, fenugreek gum 
and physical mixtures of diclofenac sodium and fenugreek 
gum were compared.
2.2.4. Formulation of FDTs
   FDTs containing 50 mg diclofenac sodium were prepared 
by direct compression method and the formulae used in 
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the study are shown in Table 1. The formulation containing 
varying proportions (for optimization) of fenugreek gum along 
with the microcrystalline cellulose as direct compressible 
diluent and mannitol as sweetening agent. To compare 
disintegration efficiency of fenugreek gum with widely used 
synthetic superdisintegrants i.e. SSG and croscarmellose 
sodium. All the ingredients were passed through # 60 
separately to attain uniformity and mixed thoroughly. The 
blended mixture was directly compressible into tablets 
with 9 mm punch using 16-station rotary tableting machine 
(Table 1).
Table 1   
Formula of different formulations of Diclofenac Sodium FDTs (mg).
Composition F1 F2 F3 F4 F5 F6 F7 F8 F9
Diclofenac sodium 50 50 50 - - - - - -
Fenugreek gum 4 8 12 - - - - - -
Sodium starch glycolate - - - 4 8 12 - - -
Croscarmellose sodium - - - - - - 4 8 12
Microcrystalline cellulose 90 86 82 90 86 82 90 86 82
Mannitol 50 50 50 50 50 50 50 50 50
Talc 3 3 3 3 3 3 3 3 3
Magnesium stearate 3 3 3 3 3 3 3 3 3
Total 200 200 200 200 200 200 200 200 200
2.2.5. Evaluation of tablets
   All the tablets were evaluated for different physical 
parameters as weight variation, hardness, friability, 
disintegration time, wetting time, drug content and in vitro 
dissolution study[11-13].
2.2.5.1. Thickness
   The thicknesses of the formulated tablets were measured 
by using Vernier callipers. 
2.2.5.2. Weight variation
   The formulated tablets were tested for weight uniformity. 
For this 20 tablets were weighed collectively and 
individually. From the collective weight, average weight 
was calculated. Each tablet’s weight was then compared 
with average weight to ascertain whether it was within 
permissible limits or not.
% Weight variation = 
Average weight
Average weight-Individual weight
×100
   
2.2.5.3. Hardness
   Hardness of tablets was measured using Pfizer type 
hardness tester. Three tablets were selected from each 
formulation randomly and their hardness was measured. The 
mean依SD of hardness values were calculated.
2.2.5.4. Friability
   Friability of the tablets was determined by using Roche 
friabilator. The weight of 20 tablets (initial weight) was 
subjected to friabilator at 25 revolutions per 4 min. Tablets 
were then dedusted, reweighed (final weight) and percentage 
loss was calculated. Friability is obtained by the following 
formula:
 % Friability = 
Initial weight
Initial weight-Final weight 
×100
2.2.5.5. Wetting time and water absorption ratio
   A double folded tissue paper was placed in a Petri dish. 
6 mL of water containing a water-soluble dye (eosin) was 
added to the Petri dish. A tablet (pre-weighed) was carefully 
placed on the surface of tissue paper. The time required for 
water to reach the upper surface of the tablet was noted as 
the wetting time. The wetted tablet was then weighed and 
the water absorption ratio (R) was determined by using the 
equation:
   R=100 (Wb-Wa)/Wb
  Where Wa and Wb are the weights of tablet before (dry 
weight) and after water absorption (wet weight) respectively.
2.2.5.6. Drug content
   Twenty tablets were weighed and powdered. The quantity 
of powder equivalent to 50 mg of diclofenac sodium was 
dissolved in phosphate buffer pH 6.8 diluted to 100 mL with 
the same and the solution was filtered and suitably diluted. 
The drug content was estimated spectrometrically at 276 nm.
 
2.2.5.7. In vitro disintegration test
   In vitro disintegration time was determined by using 
disintegration test apparatus (Electrolab, USP model ED-
2L, Mumbai) without disk for six tablets. The disintegration 
medium was 900 mL of distilled water kept at (37.0依0.5) °C 
and stirred at a rate of (30依2) r/min. The time was measured 
in seconds for complete disintegration of the tablet with 
no palpable mass remaining in the apparatus. The test was 
carried out in triplicate.
2.2.5.8. In vitro dissolution studies
   Dissolution rate was studied by using USP type II paddle 
dissolution apparatus, in 900 mL of phosphate buffer pH 6.8 
at (37.0依0.5) °C at 75 r/min. Aliquot of dissolution medium 
was withdrawn at regular time intervals and the same 
volume of pre-warmed (37依0.5) °C fresh dissolution medium 
was replaced. The samples were filtered and drug content 
of diclofenac sodium in each sample was analyzed after 
suitable dilution by Shimadzu UV-spectrophotometer at 276 nm.
2.2.6. Pharmacodynamic studies
   Pharmacodynamic study was carried out in adult male 
Wistar rats weighing 180-260 g obtained from the Animal 
House of Bapatla College of Pharmacy (1032/ac/07/CPCSEA), 
Bapatla[14]. The experiment protocol (IAEC/IV-9/BCOP/2012) 
was approved by the Institutional Animal Ethical Committee 
of Bapatla College of Pharmacy. Inflammation was induced 
in rats using Lambda carrageenan (1%) suspension. A dose of 
the tablets equivalent to human’s body weight was dissolved 
in normal saline and administered orally to the rats. After 4 h 
the percentage of inhibition of paw volume was measured.
   To study the additive anti-inflammatory activity of 
diclofenac sodium and the extract of fenugreek gum powder, 
Wistar rats (180-260 g) were divided into 4 groups, each with 
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six rats and were fasted for 18 h with free access to water. 
To Group I normal saline was administered and used as the 
negative control. For Group II, 5 mg/kg of diclofenac sodium 
was administered. For Group III, a physical mixture of 5 mg/kg of 
diclofenac sodium and 1.1 mg/kg of fenugreek gum powder 
was administered. Group IV received a 1.1 mg/kg fenugreek 
gum. 
   After 30 min, oedema was induced by injecting 0.1 mL of 
1% carageenan suspension into the sub planter region of 
right hind paw rats in all groups. The volume changes in the 
rat paw were measured by Plethysmographic technique. The 
mercury volume displaced in the Plethysmographic (the paw 
volume) was measured at the end of 4 h. 
   The anti-inflammatory activity (percentage inhibition) was 
calculated by using the formula:
    (A-B)/A伊100
   Where,  A=Mean paw volume of control (left leg); B=Mean 
paw volume of drug treated animals (right leg).
3. Results
   The fenugreek gum was extracted and evaluated for the 
physicochemical characterization as shown in Table 2. 
Compatibility study of diclofenac sodium and fenugreek 
gum were conducted by employing infrared spectral studies 
as shown in Figures 1-3. The swelling index and viscosity of 
fenugreek gum was 221% and 293.4 mpa.s respectively. The 
percent of loss on drying was observed within limit. In case 
of micromeritic studies such as bulk density was found to be 
0.396 g/cm3 and tapped density was 0.413 g/cm3. From density 
data percentage of Carr’s index was calculated as 14.11%. 
Angle of repose was found to be 22.4°. Hausner’s ratio was 
found below 1.12% indicating well acceptable limits. 
Table 2
Physicochemical characterization of fenugreek gum.
Parameters Results
pH (1%, w/v) 6.2
Loss on drying 7.54%
Swelling index 221%
Solubility Slightly soluble in cold water, But moderately 
dissolves in warm water, forms viscous 
solution, insoluble in organic solvents.
Percentage yield 26.4
Bulk density 0.396 g/cm3
Tapped density 0.413 g/cm3
Compressibility index 14.11%
Hausner’s ratio 1.042
Angle of repose 22.4°
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Figure 1. FT-IR studies of diclofenac sodium.
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   The different formulations of diclofenac sodium FDTs were 
prepared by direct compression method using fenugreek 
gum as a natural superdisintegrants, and were compared 
Table 4  
Effect of anti inflammatory activity of diclofenac sodium and fenugreek gum on caragennan induced rat paw oedema.
Groups Treatments 1st h 2nd h 3rd h 4th h % Inhibition
Group-I Control (normal saline) 0.380依0.160 0.410依0.021 0.500依0.018 0.460依0.090 -
Group-II Diclofenac sodium (5 mg/kg) 0.150依0.130 0.110依0.110 0.150依0.021 0.080依0.140 65
Group-III Diclofenac sodium (5 mg/kg)+fenugreek gum (1.1 mg/kg) 0.090依0.120 0.110依0.260 0.150依0.090 0.080依0.280 85
Group-IV Fenugreek gum (1.1 mg/kg) 0.270依0.080 0.320依0.130 0.420依0.090 0.350依0.060 23
Data are expressed as mean依SEM.
Table 3
Physical evaluation of FDTs diclofenac sodium.
Formulation Weight 
variation 
(%)
Hardness
(kg/cm2)
Thickness
(mm)
Friability
(%)
Drug 
content 
(%)
Wetting 
time
(second)
Water absorption 
test 
(%)
Disintegration 
time
 (second)
In vitro dissolution 
(cumulative % release)
F1 2.92依0.02 5.8依0.24 4.1依0.17 0.61依0.09 99.48依0.18 35 83.91依0.26 42 82.20依0.03
F2 2.93依0.02 5.6依0.08 4.1依0.29 0.66依0.03 99.46依0.16 27 88.91依0.92 33 88.80依0.03
F3 3.44依0.07 6.4依0.14 4.2依0.13 0.61依0.02 99.78依0.10 17 92.48依1.98 21 93.74依0.04
F4 2.55依0.10 6.3依0.20 4.0依0.04 0.7依0.13 99.74依0.04 51 71.20依0.19 57 73.23依0.09
F5 3.23依0.12 5.7依0.12 3.9依0.16 0.61依0.02 99.53依0.03 36 73.02依1.36 46 80.87依0.02
F6 3.16依0.09 5.8依0.16 3.9依0.04 0.63依0.10 99.82依0.02 25 81.12依0.96 34 84.93依0.01
F7 2.47依0.34 5.7依0.20 4.2依0.09 0.68依0.03 99.89依0.08 44 82.09依1.01 49 79.53依0.02
F8 2.62依0.12 5.8依0.25 4.0依0.04 0.59依0.01 99.71依0.01 31 84.18依0.88 37 85.89依0.01
F9 2.93依0.03 5.9依0.28 4.3依0.08 0.63依0.02 99.28依0.03 21 89.92依0.81 28 88.75依0.02
All values are expressed as mean依SD (n=3). 
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with various standard synthetic superdisintegrants like SSG, 
croscarmellose sodium. All the superdisintegrants were 
used in optimised concentration. The tablets were prepared 
and evaluated. Results were shown in Table 3 and Figure 
4. And the results of additive anti-inflammatory activity of 
diclofenac sodium and the extract of fenugreek gum powder 
is shown in Table 4.
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Figure 2. FT-IR studies of fenugreek gum.
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Figure 3. FI-IR Studies of physical mixture of diclofenac sodium and 
fenugreek gum.
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Figure 4. Comparative dissolution profiles of optimized formulation 
with renowed superdisintegrants. 
F3-Fenugreek gum; F6-Sodium starch glycolate; F9-Croscarmellose 
sodium.
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4. Discussion
   The method employed for the production of the fenugreek 
gum from fenugreek seeds was found to be reproducible. The 
characteristic peaks in the physical mixture of diclofenac 
sodium and fenugreek gum indicated that the gum did not 
interfere the peaks of drug confirming its compatibility. 
The physicochemical characterization adopted for the gum 
powder revealed that it possessed good swelling ratio in 
the distilled water. The rheological studies indicated that 
1% w/v gum dispersion in water had a gel like consistency 
exhibiting pseudoplastic behaviour. The flow properties of 
the powder attribute to the uniform mass of the tablets which 
is essential prior to compression to tablets. The micromeritic 
properties of gum powder such as bulk density and tapped 
density indicated good packing characteristics. Further 
the Carr’s index, Hausner’s ratio and angle of repose were 
found to be 14.11%, 1.042 and 22.40° respectively indicating 
the desirable flow properties. The formulated FDTs were 
subjected to evaluation. The weight variation of all the tablet 
formulations complied with the pharmacopeial limits. The 
hardness of the FDTs was between 5.6 to 6.4 kg/cm2 and the 
thickness was 3.8 to 4.3 mm. Hardness and thickness studies 
indicated the mechanical strength of the tablet. The percent 
friability was well within prescribed limits revealing the 
physical integrity of the tablet. The percent of drug content 
in all the formulated tablets was in the range of 99.28% 
to 99.89%, ensuring the uniformity of drug content in all 
the tablets. The wetting time of all the formulated tablets 
(F1 to F9) were found to be 17 to 51 seconds. These results 
suggested that the wetting process of the tablets were closely 
related to the inner structure of the tablets, especially pore 
size, which affects water penetration into the tablets. Of all 
the formulations, the tablets formulated with fenugreek gum 
(F3) showed the least wetting time of 17 seconds, which had a 
direct impact on high water absorption ratio (92.48依1.98)%. It 
was observed that the increased concentration of fenugreek 
gum decreased the disintegration time and optimized 
the drug release. Fenugreek gum in the concentration of 
6% acts as a eminent superdisintegrant and disintegrates 
the tablet within 21 seconds fulfilling the criteria of FDT. 
Further the higher dissolution rate of the F3 formulation 
93.74% at the end of 25 min indicated that fenugreek gum 
had a better choice among the renowned synthetic super 
disintegrating agents like SSG and croscarmellose sodium. 
From the data of in vivo studies, it was assumed that Group 
III formulation containing 5 mg/kg diclofenac sodium and 1.1 
mg/kg fenugreek gum exhibited more significant inhibition 
comparing with the other groups include the control. This 
significant anti-inflammatory activity may be due to the 
synergistic action of diclofenac sodium and fenugreek gum 
resulting in the better suppression of various inflammatory 
mediators in prostaglandin synthesis, cytokinins production 
and leucocytes migration. Hence, it can be concluded that 
the fenugreek gum acts as a good superdisintegranting agent 
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and shows promising additive anti-inflammatory activity 
with diclofenac sodium in quick relief of pain.
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Comments 
Background
   The purpose of this manuscript was to extract the 
fenugreek gum and evaluate for powder flow properties 
(bulk density, tapped density, angle of repose, Carr’s index, 
and hausner ratio), swelling index and loss on drying and 
to compare disintegration efficiency of fenugreek gum 
with widely used synthetic superdisintegrants i.e. SSG, 
croscarmellose sodium in the formulation of FDTs. All the 
superdisintegrants were used at optimized concentration 
levels to assess their efficiency. The tablets were evaluated 
for various physical tests.
Research frontiers
   The formulation of a FDT containing diclofenac sodium and 
fenugreek gum produces additive anti-inflammatory activity 
resulting in reduction in dose of diclofenac sodium and 
thereby its dose related side effects.
Related reports
  I did a search of Pub Med and I found out that there were 
not many publications on this topic, in total. Thus, this 
particular manuscript is of importance.
Innovations and breakthroughs
  As was stated in conclusion that the fenugreek gum acted 
as a good super disintegranting agent and showed promising 
additive anti-inflammatory activity with diclofenac sodium 
in quick relief of pain, it is a finding of potential importance.
  
Applications
   This finding could have potential use in clinical practice.
Peer review
   The paper is well written and interesting for reading. 
The topic of the manuscript is quite interesting and 
results are hesitating. I believe that this manucsrit could 
contribute to the knowledge in terms of design and 
evaluation of fast dissolving tablets containing diclofenac 
sodium in combination with fenugreek gum, as a natural 
superdisintegrant.
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